Watch: Melissa Hadley Barrett explains SPONTAN® real-world data presented at APCC
At the Asia-Pacific Prostate Cancer Conference (APCC) in Melbourne, Nurse Practitioner and Sexologist Melissa Hadley Barrett presented outcomes from 147 men who used SPONTAN nasal spray with
Final Phase II report confirms SPONTAN® six-fold faster absorption
LTR Pharma has received the final Clinical Study Report for its SPONTAN® Phase II pharmacokinetic study. The report completes the pharmacokinetic dataset agreed with the
LTR Pharma Expands Men’s Health Platform Through Exclusive KYZATREX® Pilot Commercialisation Agreement in Australia
LTR Pharma has entered into an exclusive pilot commercialisation agreement with Marius Pharmaceuticals, a US pharmaceutical company focused on men’s health, to introduce Marius’ lead
LTR Pharma Executes Definitive U.S. Commercial Agreement with Strive Pharmacy
LTR Pharma has executed a definitive Compounding and Supply Agreement with Strive Specialties Inc., a leading U.S. Section 503A compounding pharmacy, converting the previously announced
LTR Pharma Executes Definitive U.S. Commercial Agreement with Shed
LTR Pharma has executed a definitive Telehealth Distribution Agreement with Shed Holdings LLC, a leading U.S. direct-to-consumer telehealth platform, converting the previously announced binding Term
ROXUS® US Pharmacy Partner Secured
LTR Pharma has signed a term sheet with Strive Specialties, a United States personalised medicine and 503A pharmacy for ROXUS®. This establishes the pharmacy fulfilment infrastructure required to supply